Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Mifepristone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,601Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SameDayAbortionPills Notes Occasional Pharmacy Refusals
    SameDayAbortionPills Notes Occasional Pharmacy Refusals

    17 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251017030596/en/SameDayAbortionPills-Notes-That-While-Major-Pharmacies-Strive-to-Dispense-Abortion-Pills-Consistently-Occasional-Refusals-Still-Occur-Due-to-Individual-Human-Factors

    BUSINESSWIRE
    17 Oct 2025
    Share Share
    Optime Care Terminates Distributor Agreement for Korlym
    Optime Care Terminates Distributor Agreement for Korlym

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164304/0/en/Optime-Care-Terminates-Distributor-Agreement-for-Korlym-mifepristone.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    FDA Approves Another Generic Version of Abortion Pill
    FDA Approves Another Generic Version of Abortion Pill

    03 Oct 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-generic-version-abortion-drug-2025-10-02/

    REUTERS
    03 Oct 2025
    Share Share
    FDA Takes Close Look at Mifepristone REMS Program
    FDA Takes Close Look at Mifepristone REMS Program

    25 Sep 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-takes-close-look-mifepristone-rems-program-after-request-republican-ags

    FIERCE PHARMA
    25 Sep 2025
    Share Share
    Corcept Faces Teva Lawsuit Over Mifepristone 'Monopoly'
    Corcept Faces Teva Lawsuit Over Mifepristone 'Monopoly'

    15 Sep 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/drugmaker-corcept-must-face-teva-lawsuit-over-mifepristone-monopoly-rare-2025-09-15/

    REUTERS
    15 Sep 2025
    Share Share
    Biotech Leaders, Investors urge FDA to Preserve Access
    Biotech Leaders, Investors urge FDA to Preserve Access

    03 Jul 2025

    // BIOSPACE

    https://www.biospace.com/policy/biotech-leaders-investors-ask-fda-to-maintain-access-to-mifepristone

    BIOSPACE
    03 Jul 2025
    Share Share